Vitrolife AB (publ) (VTRLY)
USD 18.0
(7.46%)
USD 18.0
(7.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.39 Billion SEK | -20.24% |
| 2022 | 20.55 Billion SEK | 5.78% |
| 2021 | 19.42 Billion SEK | 742.87% |
| 2020 | 2.3 Billion SEK | 7.78% |
| 2019 | 2.13 Billion SEK | 25.99% |
| 2018 | 1.69 Billion SEK | 19.34% |
| 2017 | 1.42 Billion SEK | 13.75% |
| 2016 | 1.25 Billion SEK | 18.06% |
| 2015 | 1.05 Billion SEK | 8.92% |
| 2014 | 972.48 Million SEK | 99.36% |
| 2013 | 487.8 Million SEK | 5.54% |
| 2012 | 462.19 Million SEK | -0.98% |
| 2011 | 466.78 Million SEK | 8.71% |
| 2010 | 429.38 Million SEK | 19.5% |
| 2009 | 359.31 Million SEK | 4.86% |
| 2008 | 342.66 Million SEK | 14.43% |
| 2007 | 299.46 Million SEK | 10.49% |
| 2006 | 271.03 Million SEK | 28.23% |
| 2005 | 211.37 Million SEK | 13.92% |
| 2004 | 185.53 Million SEK | 0.84% |
| 2003 | 183.99 Million SEK | -2.4% |
| 2002 | 188.51 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 16.88 Billion SEK | 0.19% |
| 2024 Q2 | 16.85 Billion SEK | -0.12% |
| 2024 Q1 | 16.87 Billion SEK | 2.94% |
| 2023 Q4 | 16.39 Billion SEK | -22.61% |
| 2023 Q2 | 21.64 Billion SEK | 4.27% |
| 2023 Q1 | 20.76 Billion SEK | 1.03% |
| 2023 FY | 16.39 Billion SEK | -20.24% |
| 2023 Q3 | 21.18 Billion SEK | -2.16% |
| 2022 Q3 | 20.2 Billion SEK | 1.5% |
| 2022 Q2 | 19.9 Billion SEK | 1.9% |
| 2022 Q4 | 20.55 Billion SEK | 1.71% |
| 2022 FY | 20.55 Billion SEK | 5.78% |
| 2022 Q1 | 19.53 Billion SEK | 0.55% |
| 2021 Q1 | 2.49 Billion SEK | 8.35% |
| 2021 FY | 19.42 Billion SEK | 742.87% |
| 2021 Q3 | 6.14 Billion SEK | 144.29% |
| 2021 Q4 | 19.42 Billion SEK | 216.39% |
| 2021 Q2 | 2.51 Billion SEK | 0.65% |
| 2020 Q1 | 2.24 Billion SEK | 5.09% |
| 2020 Q4 | 2.3 Billion SEK | 2.21% |
| 2020 Q3 | 2.25 Billion SEK | 2.37% |
| 2020 FY | 2.3 Billion SEK | 7.78% |
| 2020 Q2 | 2.2 Billion SEK | -1.97% |
| 2019 Q3 | 2.09 Billion SEK | 7.15% |
| 2019 FY | 2.13 Billion SEK | 25.99% |
| 2019 Q1 | 1.88 Billion SEK | 10.76% |
| 2019 Q4 | 2.13 Billion SEK | 2.22% |
| 2019 Q2 | 1.95 Billion SEK | 3.86% |
| 2018 Q4 | 1.69 Billion SEK | 4.83% |
| 2018 Q1 | 1.55 Billion SEK | 8.98% |
| 2018 FY | 1.69 Billion SEK | 19.34% |
| 2018 Q2 | 1.56 Billion SEK | 1.05% |
| 2018 Q3 | 1.61 Billion SEK | 3.38% |
| 2017 Q4 | 1.42 Billion SEK | 7.99% |
| 2017 FY | 1.42 Billion SEK | 13.75% |
| 2017 Q3 | 1.31 Billion SEK | 1.1% |
| 2017 Q2 | 1.3 Billion SEK | 1.31% |
| 2017 Q1 | 1.28 Billion SEK | 2.85% |
| 2016 Q4 | 1.25 Billion SEK | 5.14% |
| 2016 Q1 | 1.1 Billion SEK | 4.52% |
| 2016 Q2 | 1.12 Billion SEK | 1.96% |
| 2016 FY | 1.25 Billion SEK | 18.06% |
| 2016 Q3 | 1.18 Billion SEK | 5.36% |
| 2015 Q2 | 957.27 Million SEK | -0.33% |
| 2015 Q1 | 960.44 Million SEK | -1.24% |
| 2015 Q4 | 1.05 Billion SEK | 6.66% |
| 2015 FY | 1.05 Billion SEK | 8.92% |
| 2015 Q3 | 993.13 Million SEK | 3.75% |
| 2014 Q3 | 554.34 Million SEK | 9.71% |
| 2014 Q1 | 497.44 Million SEK | 1.97% |
| 2014 FY | 972.48 Million SEK | 99.36% |
| 2014 Q4 | 972.48 Million SEK | 75.43% |
| 2014 Q2 | 505.26 Million SEK | 1.57% |
| 2013 Q4 | 487.8 Million SEK | 4.4% |
| 2013 Q2 | 479.56 Million SEK | 2.95% |
| 2013 Q3 | 467.23 Million SEK | -2.57% |
| 2013 Q1 | 465.84 Million SEK | 0.79% |
| 2013 FY | 487.8 Million SEK | 5.54% |
| 2012 Q3 | 495.29 Million SEK | -1.23% |
| 2012 Q1 | 473.88 Million SEK | 1.52% |
| 2012 Q2 | 501.47 Million SEK | 5.82% |
| 2012 Q4 | 462.19 Million SEK | -6.68% |
| 2012 FY | 462.19 Million SEK | -0.98% |
| 2011 FY | 466.78 Million SEK | 8.71% |
| 2011 Q4 | 466.78 Million SEK | 0.82% |
| 2011 Q2 | 442.13 Million SEK | 1.3% |
| 2011 Q1 | 436.47 Million SEK | 1.65% |
| 2011 Q3 | 463 Million SEK | 4.72% |
| 2010 Q3 | 388.25 Million SEK | -0.29% |
| 2010 FY | 429.38 Million SEK | 19.5% |
| 2010 Q2 | 389.39 Million SEK | 0.0% |
| 2010 Q4 | 429.38 Million SEK | 10.6% |
| 2009 Q4 | 359.31 Million SEK | 0.0% |
| 2009 FY | 359.31 Million SEK | 4.86% |
| 2008 FY | 342.66 Million SEK | 14.43% |
| 2007 FY | 299.46 Million SEK | 10.49% |
| 2006 FY | 271.03 Million SEK | 28.23% |
| 2005 FY | 211.37 Million SEK | 13.92% |
| 2004 FY | 185.53 Million SEK | 0.84% |
| 2003 FY | 183.99 Million SEK | -2.4% |
| 2002 FY | 188.51 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| IR-Med Inc. | 999 Thousand USD | -1640640.741% |
| Polarean Imaging plc | 10.86 Million USD | -150729.118% |
| Avitar, Inc. | 1.74 Million USD | -937694.116% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -1882254.833% |
| CVR Medical Corp. | - USD | -Infinity% |
| AVITA Medical, Inc. | 144.33 Million USD | -11255.827% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -5186925.316% |
| Össur hf. | 1.39 Billion USD | -1075.984% |
| Zecotek Photonics Inc. | 2.57 Million USD | -636964.969% |
| QHSLab, Inc. | 1.68 Million USD | -974723.841% |
| Wellstar International, Inc. | 957.89 Thousand USD | -1711053.241% |
| Össur hf. | 1.39 Billion USD | -1075.984% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | -15825.842% |
| Escalon Medical Corp. | 4.75 Million USD | -344398.915% |
| Aurora Spine Corporation | 11.92 Million USD | -137365.074% |
| BrainsWay Ltd. | 62.97 Million USD | -25929.029% |
| BioElectronics Corporation | 144.38 Thousand USD | -11351951.417% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | -574407.177% |
| Hamilton Thorne Ltd. | 110.16 Million USD | -14778.803% |
| Vivos Inc. | 1.61 Million USD | -1017896.129% |
| MicroPort Scientific Corporation | 3.93 Billion USD | -316.932% |
| Kelyniam Global, Inc. | 1.63 Million USD | -1003823.577% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -1358667.286% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -29938893.205% |
| Nanomix Corporation | 982.05 Thousand USD | -1668951.122% |
| Theraclion SA | 18.66 Million EUR | -87723.498% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -8997045.68% |
| Positron Corporation | 1.76 Million USD | -927176.327% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -2190088.714% |
| Lombard Medical, Inc. | 67.76 Million USD | -24087.289% |
| ALR Technologies Inc. | 193.21 Thousand USD | -8483107.999% |
| Stratec SE | 529.71 Million USD | -2994.312% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -1651722.336% |
| Heart Tronics, Inc. | 4.04 Million USD | -404722.403% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -740891.892% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -79695.063% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -73021.877% |
| VMS Rehab Systems, Inc. | 4.45 USD | -368337078551.685% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -981985.081% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -2221691.476% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -3596050.007% |
| United American Healthcare Corporation | 10.37 Million USD | -157824.656% |
| ECGI Holdings, Inc. | 5.2 Million USD | -315026.212% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -48502592.786% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -766290.116% |
| Urologix, Inc. | 5.66 Million USD | -289135.927% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -726909.022% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -80439.74% |
| SS Innovations International, Inc. | 25.47 Million USD | -64231.193% |
| Qualis Innovations, Inc. | 2431.00 USD | -674249180.132% |
| Smith & Nephew plc | 9.97 Billion USD | -64.355% |
| NIOX Group Plc | 116.47 Million USD | -13972.004% |
| Fuse Medical, Inc. | 16.25 Million USD | -100710.779% |
| Broncus Holding Corporation | 195.75 Million USD | -8273.356% |
| Brain Scientific Inc. | 11.74 Million USD | -139473.598% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -1561429.462% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -57041834.923% |